NRX Pharmaceuticals
NRXP
NRXP
38 hedge funds and large institutions have $12.4M invested in NRX Pharmaceuticals in 2021 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 9 increasing their positions, 6 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
19% less call options, than puts
Call options by funds: $2.92M | Put options by funds: $3.63M
24% less capital invested
Capital invested by funds: $16.2M → $12.4M (-$3.84M)
Holders
38
Holding in Top 10
–
Calls
$2.92M
Puts
$3.63M
Top Buyers
| 1 | +$2.46M | |
| 2 | +$823K | |
| 3 | +$791K | |
| 4 |
VF
Virtu Financial
New York
|
+$294K |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$173K |
Top Sellers
| 1 | -$1.42M | |
| 2 | -$1.25M | |
| 3 | -$166K | |
| 4 |
Jane Street
New York
|
-$111K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$72K |